Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Choose up to three clusters

Side by side

Dimension	Teesside & the HumberNorth East / Yorkshire and the Humber	CambridgeEast of England	Leeds & West YorkshireYorkshire and the Humber
Sectors	Clean Energy, Advanced Manufacturing, Advanced Materials Supporting: Digital Technologies, AgriTech & FoodTech	Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies	Life Sciences, Digital Technologies, Financial Technology Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries
Research	Not recorded on the map.	University of Cambridge Wellcome Sanger Institute MRC Laboratory of Molecular Biology	University of Leeds
Companies	Not recorded on the map.	Cambridge semiconductor and processor IP cluster	Leeds health data and digital health cluster
Infrastructure	Centre for Process Innovation Process innovation and biologics scale-up facilities, port capacity and grid-connected industrial land.	Babraham Research Campus Cambridge Science Park University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.	Not recorded on the map. Health data infrastructure, teaching hospitals and university research facilities.
Capital	Infrastructure capital, corporate investment and public programmes; almost no local venture base.	Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.	Financial services depth locally, but early-stage health technology capital remains limited.
Government programmes	Teesside Freeport — Freeports Humber Freeport — Freeports	No place-based designation recorded.	No place-based designation recorded.
What exists	The largest concentration of industrial decarbonisation activity in the UK: hydrogen, carbon capture, process manufacturing, biologics scale-up capability and two Freeports with substantial serviced industrial land.	Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.	National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.
What's missing · UKIZ interpretation	Skills pipelines and company formation. The land, power and permits exist; the innovation companies and the technical workforce to fill them do not yet exist at the same scale.	Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.	A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.
What could connect · UKIZ interpretation	Industrial land and process scale-up capability connected to research clusters elsewhere that have technologies without a place to build them — a national scale-up site rather than a regional one.	Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.	Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.
UKIZ relevance	This is where Britain either builds an energy supply chain or imports one. The proposed Teesside & Humber mission is explicitly about retained industrial capability.	Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.	Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.
Last verified	15 August 2026	15 August 2026	15 August 2026

Proposed by UKIZ · independent · not a government designation

Back to the map →Methodology →